338 related articles for article (PubMed ID: 24089018)
1. Is lipoprotein-associated phospholipase A2 activity correlated with fibrous-cap thickness and plaque volume in patients with acute coronary syndrome?
Gu X; Hou J; Yang S; Yu H; Tian J; Liu F; Li N; Yu B; Jang IK
Coron Artery Dis; 2014 Jan; 25(1):10-5. PubMed ID: 24089018
[TBL] [Abstract][Full Text] [Related]
2. Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome.
Dohi T; Miyauchi K; Okazaki S; Yokoyama T; Ohkawa R; Nakamura K; Yanagisawa N; Tsuboi S; Ogita M; Yokoyama K; Kurata T; Yatomi Y; Daida H
Atherosclerosis; 2011 Dec; 219(2):907-12. PubMed ID: 22024276
[TBL] [Abstract][Full Text] [Related]
3. The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound.
Takarada S; Imanishi T; Ishibashi K; Tanimoto T; Komukai K; Ino Y; Kitabata H; Kubo T; Tanaka A; Kimura K; Mizukoshi M; Akasaka T
JACC Cardiovasc Interv; 2010 Jul; 3(7):766-72. PubMed ID: 20650439
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of lipoprotein-associated phosholipase A2 and plaque burden/composition in young adults.
Celik O; Ozturk D; Akin F; Satilmis S; Yalcin AA; Erturk M; Ayca B; Akturk F; Birand A; Pusuroglu H; Kaya MG
Coron Artery Dis; 2015 May; 26(3):266-71. PubMed ID: 25647459
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Intensive Versus Moderate Lipid-Lowering Therapy on Fibrous Cap and Atheroma Volume of Coronary Lipid-Rich Plaque Using Serial Optical Coherence Tomography and Intravascular Ultrasound Imaging.
Hou J; Xing L; Jia H; Vergallo R; Soeda T; Minami Y; Hu S; Yang S; Zhang S; Lee H; Yu B; Jang IK
Am J Cardiol; 2016 Mar; 117(5):800-6. PubMed ID: 26778524
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-Associated Phospholipase A2 in Cardiac Disease: a Potential Early Biomarker of Unstable Coronary Artery Disease.
Li J; Zhou Z; Niu X; Li H
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390386
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis.
Kolodgie FD; Burke AP; Skorija KS; Ladich E; Kutys R; Makuria AT; Virmani R
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2523-9. PubMed ID: 16960105
[TBL] [Abstract][Full Text] [Related]
9. Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.
Yang F; Ma L; Zhang L; Wang Y; Zhao C; Zhu W; Liang W; Liu Q
Heart Vessels; 2019 Oct; 34(10):1608-1614. PubMed ID: 30963302
[TBL] [Abstract][Full Text] [Related]
10. Plasma Lp-PLA2 in acute coronary syndrome: association with major adverse cardiac events in a community-based cohort.
Li N; Li S; Yu C; Gu S
Postgrad Med; 2010 Jul; 122(4):200-5. PubMed ID: 20675983
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between serum inflammatory cytokine levels and fibrous cap thickness of fibrofatty plaque in coronary culprit lesions].
Zhong Y; Ye F; You W; Wu ZM
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jul; 45(7):566-571. PubMed ID: 28738484
[No Abstract] [Full Text] [Related]
12. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K
JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein-associated phospholipase A2 and coronary calcification. The Rotterdam Coronary Calcification Study.
Kardys I; Oei HH; Hofman A; Oudkerk M; Witteman JC
Atherosclerosis; 2007 Apr; 191(2):377-83. PubMed ID: 16678183
[TBL] [Abstract][Full Text] [Related]
15. Long-term darapladib use does not affect coronary plaque composition assessed using multimodality intravascular imaging modalities: a randomized-controlled study.
Choi WG; Prasad M; Lennon R; Gulati R; Prasad A; Lerman LO; Lerman A
Coron Artery Dis; 2018 Mar; 29(2):104-113. PubMed ID: 29135482
[TBL] [Abstract][Full Text] [Related]
16. Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.
Nasu K; Terashima M; Habara M; Ko E; Ito T; Yokota D; Ishizuka S; Kurita T; Kimura M; Kinoshita Y; Asakura Y; Tsuchikane E; Katoh O; Suzuki T
JACC Cardiovasc Interv; 2013 Jul; 6(7):746-55. PubMed ID: 23769651
[TBL] [Abstract][Full Text] [Related]
17. Association of circulating levels of neopterin with non-culprit plaque vulnerability in CAD patients an angiogram, optical coherent tomography and intravascular ultrasound study.
Sun Y; He J; Tian J; Xie Z; Wang C; Yu B
Atherosclerosis; 2015 Jul; 241(1):138-42. PubMed ID: 25982822
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients.
Maiolino G; Pedon L; Cesari M; Frigo AC; Wolfert RL; Barisa M; Pagliani L; Rossitto G; Seccia TM; Zanchetta M; Rossi GP
PLoS One; 2012; 7(10):e48171. PubMed ID: 23118945
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) is an important factor to determine coronary artery plaque morphology in patients with acute myocardial infarction.
Hikita H; Shigeta T; Kojima K; Oosaka Y; Hishikari K; Kawaguchi N; Nakashima E; Sugiyama T; Akiyama D; Kamiishi T; Kimura S; Takahashi Y; Kuwahara T; Sato A; Takahashi A; Isobe M
Coron Artery Dis; 2013 Aug; 24(5):381-5. PubMed ID: 23652366
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease.
Niccoli G; Cin D; Scalone G; Panebianco M; Abbolito S; Cosentino N; Jacoangeli F; Refaat H; Gallo G; Salerno G; Volpe M; Crea F; De Biase L
Atherosclerosis; 2016 Mar; 246():214-20. PubMed ID: 26803430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]